ImmunityBio (IBRX) is up 22.2%, or 67c to $3.69.
Easter Sale - 70% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IBRX:
- Unusually active option classes on open January 15th
- Midday Fly By: Big banks report mixed quarterly results
- Unusually active option classes on open January 14th
- Saudi FDA approves ImmunityBio’s ANKTIVA for bladder cancer treatment
- Saudi FDA grants accelerated approval to ImmunityBio’s ANKTIVA for NSCLC